Health · Public Health & Disease · 8 hrs ago
ICMR finds common antibiotics losing effectiveness in Indian hospitals
The ICMR found common antibiotics are becoming less effective against bacterial infections in Indian hospitals.
Its 2025 surveillance report found that only 18.4% of tested E. coli samples were susceptible to cefotaxime, used for serious infections including pneumonia and urinary tract infections.
Only about one-third of Klebsiella pneumoniae samples were susceptible to carbapenems, powerful drugs often kept for severe infections that do not respond to other medicines.
The report also found 91.1% of tested Acinetobacter baumannii samples resisted carbapenems; this bacterium can cause serious infections in hospital patients, including pneumonia and bloodstream infections.
The findings show drug resistance is not limited to major referral hospitals, and ceftriaxone susceptibility in E. coli fell from 39.8% in one category of secondary-care hospitals to 11.5% in another.
Antibiotic resistance makes infections harder to treat, while health officials have raised concerns about sales without prescriptions and inappropriate prescribing.
The report gives no specific next steps, but the government has highlighted antibiotic misuse during World Antimicrobial Resistance Awareness Week.
An Indian Council of Medical Research report found that common antibiotics are increasingly ineffective against bacteria in Indian hospitals.
Only 18.4% of tested E. coli samples were susceptible to cefotaxime, used to treat serious infections including pneumonia and urinary tract infections.
The report also found that only around one-third of Klebsiella pneumoniae samples were susceptible to carbapenems.
Among revived Acinetobacter baumannii isolates, 91.1% were resistant to carbapenems.
ICMR said the findings show antimicrobial resistance is not limited to large referral centres.
- Who
- The Indian Council of Medical Research reported the findings. Hospital patients and people with bacterial infections are affected.
- What
- Common antibiotics are losing effectiveness as antimicrobial resistance rises.
- When
- The findings are from ICMR’s annual report for 2025, published on November 22, 2026.
- Where
- Indian hospitals.
- Why
- The report points to rising antimicrobial resistance. The article also notes concerns about antibiotic sales without prescriptions and inappropriate prescribing.
This story does not have two clearly opposing sides.
ICMR’s annual Antimicrobial Resistance Surveillance and Research Network report recorded the hospital findings.
The health ministry highlighted concerns over antibiotic sales without prescriptions and inappropriate prescribing at the launch of World Antimicrobial Resistance Awareness Week.
The Times of India published its report on ICMR’s findings.
- E. coli susceptibility to cefotaxime
- 18.4% of samples tested
- Klebsiella pneumoniae susceptibility to carbapenems
- Around one-third of samples
- Acinetobacter baumannii resistance to carbapenems
- 91.1% of revived isolates
- E. coli susceptibility to ceftriaxone
- 39.8% in category I hospitals; 28% in category II; 11.5% in category III
- Report
- ICMR Antimicrobial Resistance Surveillance and Research Network annual report for 2025
What people are saying
the findings showed antimicrobial resistance was not confined to large referral centres